Dj. Goldhamer et al., EMBRYONIC ACTIVATION OF THE MYOD GENE IS REGULATED BY A HIGHLY CONSERVED DISTAL CONTROL ELEMENT, Development, 121(3), 1995, pp. 637-649
MyoD belongs to a small family of basic helix-loop-helix transcription
factors implicated in skeletal muscle lineage determination and diffe
rentiation. Previously, we identified a transcriptional enhancer that
regulates the embryonic expression of the human myoD gene. This enhanc
er had been localized to a 4 kb fragment located 18 to 22 kb upstream
of the myoD transcriptional start site. We now present a molecular cha
racterization of this enhancer. Transgenic and transfection analyses l
ocalize the myoD enhancer to a core sequence of 258 bp. In transgenic
mice, this enhancer directs expression of a lacZ reporter gene to skel
etal muscle compartments in a spatiotemporal pattern indistinguishable
from the normal myoD expression domain, and distinct from expression
patterns reported for the other myogenic factors. In contrast to the m
yoD promoter, the myoD enhancer shows striking conservation between hu
mans and mice both in its sequence and its distal position. Furthermor
e, a myoD enhancer/heterologous promoter construct exhibits muscle-spe
cific expression in transgenic mice, demonstrating that the myoD promo
ter is dispensable for myoD activation. With the exception of E-boxes,
the myoD enhancer has no apparent sequence similarity with regulatory
regions of other characterized muscle-specific structural or regulato
ry genes. Mutation of these E-boxes, however, does not affect the patt
ern of lacZ transgene expression, suggesting that myoD activation in t
he embryo is E-box-independent, DNase I protection assays reveal multi
ple nuclear protein binding sites in the core enhancer, although none
are strictly muscle-specific. Interestingly, extracts from myoblasts a
nd 10T1/2 fibroblasts yield identical protection profiles, indicating
a similar complement of enhancer-binding factors in muscle and this no
n-muscle cell type. However, a clear difference exists between myoblas
ts and 10T1/2 cells (and other non-muscle cell types) in the chromatin
structure of the chromosomal myoD core enhancer, suggesting that the
myoD enhancer is repressed by epigenetic mechanisms in 10T1/2 cells. T
hese data indicate that myoD activation is regulated at multiple level
s by mechanisms that are distinct from those controlling other charact
erized muscle-specific genes.